Web Exclusives

Low-dose chemoimmunotherapy may be an effective first-line therapy for certain patients with chronic lymphocytic leukemia and particular biological and genetic features. Read More ›

By keeping themselves physically and emotionally healthy, caregivers can give their loved ones the best possible support when helping to care for them. Read More ›

June is Pride Month, and the LGBTQ patient population with cancer faces a disproportionate burden because of a lack of data, a misunderstanding of this population by providers, and a lack of resources and education for patients. Read More ›

We have all been affected by the coronavirus pandemic in some way. For cancer survivors, it can be difficult to process the time lost to COVID-19 after surviving the hardships of cancer treatment. Read More ›

The COVID-19 pandemic has resulted in several changes in how patients with chronic lymphocytic leukemia (CLL) are treated. Read More ›

Better identification of patients at high risk of disease progression and newer treatments may mean that fewer newly diagnosed patients must “watch and wait.” Read More ›

The use of telemedicine has shown rapid growth over the course of the pandemic, with some experts suggesting that it is here to stay. Read More ›

Can a digital coach improve health outcomes in patients with blood cancers? An ongoing clinical trial should provide insights. Read More ›

Three patients with chronic lymphocytic leukemia were found to have progression to B-ALL after treatment with lenalidomide causing early termination of a clinical study. Read More ›

Michele Lawson founded Wig Warriors in honor of her stepmother, who passed away from colon cancer. The Wig Warriors Foundation provides services to patients who have cosmetic side effects from cancer treatments. Read More ›